These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 7324603)

  • 1. [The effectiveness of radiologic skeletal diagnosis (combination of skeletal scintigraphy with roentgen diagnosis) for the determination of bone metastases in breast cancer].
    Schalldach U; Drescher W; Endert G; Hegemann R; Keinert K; Schumann E
    Zentralbl Chir; 1981; 106(20):1383-6. PubMed ID: 7324603
    [No Abstract]   [Full Text] [Related]  

  • 2. [Bone metastasis in breast carcinoma].
    Kölbl O; Kiricuta IC; Willner J; Flentje M
    Zentralbl Chir; 1997; 122(2):97-102. PubMed ID: 9173765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Personal experience with thermographic studies of skeletal metastasis of breast cancer].
    Fiore M; Burke P; Boidi Trotti A; Temporelli A
    Arch Sci Med (Torino); 1979; 136(2):289-93. PubMed ID: 518281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Stepwise combination of skeletal scintigram and x-rays in the improvement and rationalisation of skeletal metastases detection (author's transl)].
    Zechmann W; Falkensammer M; Wacker H; Jakse G; Zambelis N
    Wien Klin Wochenschr; 1981 Apr; 93(8):261-5. PubMed ID: 7257418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnostic value of whole-body MRI and bone scintigraphy in the detection of osseous metastases in patients with breast cancer--A Prospective Double-Blinded Study at two Hospital Centers].
    Ohlmann-Knafo S; Kirschbaum M; Fenzl G; Pickuth D
    Rofo; 2009 Mar; 181(3):255-63. PubMed ID: 19229791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relative use of eight collagenous and noncollagenous markers for diagnosis of skeletal metastases in breast, prostate, or lung cancer patients.
    Leeming DJ; Koizumi M; Byrjalsen I; Li B; Qvist P; Tankó LB
    Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):32-8. PubMed ID: 16434583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone imaging in metastatic breast cancer.
    Hamaoka T; Madewell JE; Podoloff DA; Hortobagyi GN; Ueno NT
    J Clin Oncol; 2004 Jul; 22(14):2942-53. PubMed ID: 15254062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination and biological relevance of serum cross-linked type I collagen N-telopeptide and bone-specific alkaline phosphatase in breast metastatic cancer.
    Kanakis I; Nikolaou M; Pectasides D; Kiamouris C; Karamanos NK
    J Pharm Biomed Anal; 2004 Mar; 34(4):827-32. PubMed ID: 15019061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Elevation of serum Ca 15-3 antigen: an early indicator of distant metastasis from breast cancer. Retrospective analysis of 733 cases].
    Wojtacki J; Kruszewski WJ; Sliwińska M; Kruszewska E; Hajdukiewicz W; Sliwiński W; Rolka-Stempniewicz G; Góralczyk M; Leśniewski-Kmak K
    Przegl Lek; 2001; 58(6):498-503. PubMed ID: 11816740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnosis of metastasis of breast cancer to the thorax and bones].
    Frohberg HD
    Z Arztl Fortbild (Jena); 1991 Oct; 85(20):1007-13. PubMed ID: 1776282
    [No Abstract]   [Full Text] [Related]  

  • 11. Fas/Fas-ligand expressions in primary breast cancer are significant predictors of its skeletal spread.
    Bebenek M; Duś D; Koźlak J
    Anticancer Res; 2007; 27(1A):215-8. PubMed ID: 17352235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Thermography in the diagnosis of bone metastases].
    Viganotti G
    Radiol Med; 1981 Apr; 67(4):252-3. PubMed ID: 7313159
    [No Abstract]   [Full Text] [Related]  

  • 13. Monitoring of bone metastases.
    Galasko CS
    Schweiz Med Wochenschr; 1981 Dec; 111(49):1873-5. PubMed ID: 7330641
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of bisphosphonates in breast cancer.
    Coleman RE
    Breast; 2004 Dec; 13 Suppl 1():S19-28. PubMed ID: 15585379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic value of bone remodeling markers in the diagnosis of bone metastases in patients with breast cancer.
    Pectasides D; Farmakis D; Nikolaou M; Kanakis I; Kostopoulou V; Papaconstantinou I; Karamanos NK; Economopoulos T; Raptis SA
    J Pharm Biomed Anal; 2005 Feb; 37(1):171-6. PubMed ID: 15664758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral pamidronate in the prevention and treatment of skeletal metastases in patients with breast cancer.
    van Holten-Verzantvoort AT; Papapoulos SE
    Medicina (B Aires); 1997; 57 Suppl 1():109-13. PubMed ID: 9567363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of whole body MRI and radioisotope bone scintigram for skeletal metastases detection.
    Chan Y; Chan K; Lam W; Metreweli C
    Chin Med J (Engl); 1997 Jun; 110(6):485-9. PubMed ID: 9594253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alkaline phosphatase isoenzymes in detection and follow up of breast cancer metastases.
    Ritzke C; Stieber P; Untch M; Nagel D; Eiermann W; Fateh-Moghadam A
    Anticancer Res; 1998; 18(2B):1243-9. PubMed ID: 9615795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment results with skeletal metastases of breast cancer from 1972 to 1978].
    Mandolini G; Falchi AM; De Maria D; Ceresatto E; Roli F; Santantonio M
    Radiol Med; 1980; 66(1-2):77-8. PubMed ID: 7455217
    [No Abstract]   [Full Text] [Related]  

  • 20. [Detection of bone metastasis of prostate cancer - comparison of whole-body MRI and bone scintigraphy].
    Ketelsen D; Röthke M; Aschoff P; Merseburger AS; Lichy MP; Reimold M; Claussen CD; Schlemmer HP
    Rofo; 2008 Aug; 180(8):746-52. PubMed ID: 18512192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.